Goteri, G <br/><br/>
Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.  [electronic resource] 

 -  The British journal of dermatology  May 2012 
 - 948-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2133.2012.10818.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Chemokine CCL27--metabolism<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Mycosis Fungoides--blood<br/>Neoplasm Recurrence, Local--etiology<br/>PUVA Therapy--methods<br/>Prospective Studies<br/>Recombinant Proteins--therapeutic use<br/>Risk Factors<br/>Skin Neoplasms--drug therapy<br/>Treatment Outcome<br/>Young Adult